sglt2 glp 1 Renal outcomes of inhibitors and GLP1 agonists in clinical practice Recommendations for SGLT2i versus GLP-1
Description
These behaviors often center around food-related problems, like searching for and saving food, acting on impulse, and repeatedly asking for food
Participants lost up to 13.1% of their body weight on Mounjaro 15 mg, versus 6.7% with semaglutide
Results showed that people with HS prescribed GLP-1 receptor agonists were 65% less likely to undergo an HS-related surgery (HR = 0.35
Am I a Good Candidate for GLP-1 agonist
It is built on a guiding principle of using a low dose first
Follow-up visits will occur at baseline, three months, and six months to track outcomes
